167 related articles for article (PubMed ID: 17562783)
1. Mode of death in patients with systolic heart failure.
Patel J; Heywood JT
J Cardiovasc Pharmacol Ther; 2007 Jun; 12(2):127-36. PubMed ID: 17562783
[TBL] [Abstract][Full Text] [Related]
2. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial.
Carson P; Anand I; O'Connor C; Jaski B; Steinberg J; Lwin A; Lindenfeld J; Ghali J; Barnet JH; Feldman AM; Bristow MR
J Am Coll Cardiol; 2005 Dec; 46(12):2329-34. PubMed ID: 16360067
[TBL] [Abstract][Full Text] [Related]
3. The role of beta-blockers in preventing sudden death in heart failure.
Teerlink JR; Massie BM
J Card Fail; 2000 Jun; 6(2 Suppl 1):25-33. PubMed ID: 10908095
[TBL] [Abstract][Full Text] [Related]
4. The role of beta-adrenergic blocking agents in preventing sudden cardiac death.
Pitt B
Circulation; 1992 Jan; 85(1 Suppl):I107-11. PubMed ID: 1345815
[TBL] [Abstract][Full Text] [Related]
5. Using Cardicor as first-line therapy in heart failure : CiBis iii.
Cardiovasc J Afr; 2009; 20(1):78. PubMed ID: 19382368
[No Abstract] [Full Text] [Related]
6. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockers for preventing sudden cardiac death.
Giles TD; Basile JN
Postgrad Med; 2003 Dec; 114(6 Suppl Role):30-4. PubMed ID: 19667667
[TBL] [Abstract][Full Text] [Related]
8. [Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
MMW Fortschr Med; 2005 Sep; 147(39):10. PubMed ID: 16245769
[No Abstract] [Full Text] [Related]
9. [Longevity promoting beta blocker. Soon in 1st place in heart failure?].
MMW Fortschr Med; 2003 Sep; 145(37):60. PubMed ID: 14584447
[No Abstract] [Full Text] [Related]
10. Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers.
Flannery G; Gehrig-Mills R; Billah B; Krum H
Am J Cardiol; 2008 Mar; 101(6):865-9. PubMed ID: 18328855
[TBL] [Abstract][Full Text] [Related]
11. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
[TBL] [Abstract][Full Text] [Related]
12. The effect of beta-blockers on morbidity and mortality associated with heart failure.
Goldstein S
Am J Manag Care; 2000 Apr; 6(6 Suppl):S308-12. PubMed ID: 11010426
[No Abstract] [Full Text] [Related]
13. Prediction of mode of death in heart failure: the Seattle Heart Failure Model.
Mozaffarian D; Anker SD; Anand I; Linker DT; Sullivan MD; Cleland JG; Carson PE; Maggioni AP; Mann DL; Pitt B; Poole-Wilson PA; Levy WC
Circulation; 2007 Jul; 116(4):392-8. PubMed ID: 17620506
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
15. Incidence and predictors of sudden cardiac death in patients with diastolic heart failure.
Al-Khatib SM; Shaw LK; O'Connor C; Kong M; Califf RM
J Cardiovasc Electrophysiol; 2007 Dec; 18(12):1231-5. PubMed ID: 17883404
[TBL] [Abstract][Full Text] [Related]
16. Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (MOST): implications for device selection in elderly patients with sinus node disease.
Sweeney MO; Hellkamp AS; Ellenbogen KA; Lamas GA
J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1160-6. PubMed ID: 18554201
[TBL] [Abstract][Full Text] [Related]
17. Heart rate turbulence and death due to cardiac decompensation in patients with chronic heart failure.
Moore RK; Groves DG; Barlow PE; Fox KA; Shah A; Nolan J; Kearney MT
Eur J Heart Fail; 2006 Oct; 8(6):585-90. PubMed ID: 16473041
[TBL] [Abstract][Full Text] [Related]
18. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
[TBL] [Abstract][Full Text] [Related]
19. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
[TBL] [Abstract][Full Text] [Related]
20. Diabetes does not affect ventricular repolarization and sudden cardiac death risk in patients with dilated cardiomyopathy.
Vrtovec B; Fister M; Poglajen G; Starc V; Haddad F
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S146-50. PubMed ID: 19250080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]